Form 4: Health Catalyst CEO Sells Shares to Cover Tax Obligations

Health Catalyst CEO Daniel D. Burton sold 4,442 shares of common stock on June 3, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On June 3, 2024, Daniel D. Burton, CEO of Health Catalyst, Inc. (HCAT), sold 4,442 shares of common stock.
• The sale was executed at a price of $6.5333 per share.
• The transaction was mandated by Health Catalyst's equity incentive plans to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Burton directly owns 1,163,208 shares of Health Catalyst common stock.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to stock transactions for tax purposes. It doesn't indicate any significant positive or negative sentiment, but the fact that the CEO is selling shares, even for tax purposes, could be perceived neutrally to slightly negatively.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among executives in publicly traded companies.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates